Neurobiological Technologies to wind down operations
This article was originally published in Scrip
Executive Summary
Neurobiological Technologies plans to liquidate its assets and dissolve the company following a review of its strategic alternatives. The firm's board approved the plan last week after it failed to find a buyer for the business.